New Drug to Prevent Bone Loss Caused by Breast Cancer Treatment

[tousled1]

SAN ANTONIO, Dec. 15 /PRNewswire/ -- Denosumab is a new drug being studied to prevent fractures in breast cancer patients receiving hormonal therapy. Results of a phase 3 clinical trial using denosumab were presented Friday evening at the San Antonio Breast Cancer Symposium by Georgiana Ellis, MD, from the Seattle Cancer Care Alliance.

full article: http://sev.prnewswire.com/biotechnology/20071215/NYSA00615122007-1.html

[Bev]

Sign me up! BB

[suzan w]

me too!!! wonder why no one I see for my treatment (at another facility in Seattle) has heard of this?????